clomipramine has been researched along with Cognitive Decline in 2 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, N | 1 |
| Fang, YC | 1 |
| Lee, HY | 1 |
| Singh, A | 1 |
| Nepali, K | 1 |
| Lin, MH | 1 |
| Yeh, TK | 1 |
| Lai, MJ | 1 |
| Chan, L | 1 |
| Tu, YK | 1 |
| Banerjee, S | 1 |
| Hu, CJ | 1 |
| Liou, JP | 1 |
| Paolini Paoletti, F | 1 |
| Di Gregorio, M | 1 |
| Calabresi, P | 1 |
| Parnetti, L | 1 |
2 other studies available for clomipramine and Cognitive Decline
| Article | Year |
|---|---|
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment.
Topics: Animals; Azepines; Cell Line, Tumor; Clomipramine; Cognitive Dysfunction; Dementia, Vascular; Dose-R | 2020 |
Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosis.
Topics: Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Cognitive Dysfunction; Creutzfe | 2018 |